Therapy News and Research

RSS

Value of pathology review highlighted in node-negative breast cancer

Secondary pathology review results in significant changes in diagnosis and treatment for women with node-negative breast cancer, Canadian researchers report.

20 Jun 2012

Engaging in daily activities with children can reduce stress among single mothers

A group of three Kansas State University researchers is studying ways to help single mothers improve their relationship with their children.

20 Jun 2012

NewYork-Presbyterian/WCMC join new MDS Clinical Research Consortium

NewYork-Presbyterian/Weill Cornell Medical Center is one of six institutions selected to join the newly-founded MDS Clinical Research Consortium.

20 Jun 2012

HCHD to offer APTA-accredited post-professional physical therapy residency programs

The Harris County Hospital District joins only one other public healthcare system in the nation to offer two post-professional physical therapy residency programs with the recent accreditation of the Neurologic Physical Therapy Residency by the American Physical Therapy Association.

20 Jun 2012

Bariatric procedure increases risk of alcohol use disorders two years after surgery

Adults who had a common bariatric surgery to lose weight had a significantly higher risk of alcohol use disorders (AUD) two years after surgery, according to a study by a National Institutes of Health research consortium.

20 Jun 2012

Study identifies critical neurological factor in aggression

Pathological rage can be blocked in mice, researchers have found, suggesting potential new treatments for severe aggression, a widespread trait characterized by sudden violence, explosive outbursts and hostile overreactions to stress.

20 Jun 2012

Young men with HIV more likely to experience low bone mass

Young men being treated for HIV are more likely to experience low bone mass than are other men their age, according to results from a research network supported by the National Institutes of Health. The findings indicate that physicians who care for these patients should monitor them regularly for signs of bone thinning, which could foretell a risk for fractures. The young men in the study did not have HIV at birth and had been diagnosed with HIV an average of two years earlier.

20 Jun 2012

Combination therapy may help defeat pancreatic cancer

Combining a new targeted therapy with standard chemotherapy may help defeat pancreatic cancer, according to results presented at the American Association for Cancer Research's Pancreatic Cancer: Progress and Challenges conference, held here June 18-21.

20 Jun 2012

Emergence of drug resistance to ARVs has potential to 'curb, and even reverse' gains against HIV

Noting that the "roll-out of antiretroviral treatment for HIV in sub-Saharan Africa has been accompanied by rising rates of drug resistance," Raph Hamers, a global health research fellow at the Academic Medical Centre of the University of Amsterdam, and colleagues "call for improved patient management and the integration of population-based drug resistance surveillance into national treatment programs" in this BMJ analysis.

20 Jun 2012

Inserm researchers examine effect of night work on women’s health

Breast cancer is the number one cause of female mortality. It affects 100 out of 100,000 women per year in developed countries. Each year, more than 1.3 million new cases are diagnosed, 53,000 of these in France. The risk factors of breast cancer are varied. They include genetic mutations, late first pregnancy, low parity or hormone therapy, but other causes of breast cancer such as way of life, environmental or professional causes have not yet been completely identified.

20 Jun 2012

KPT-SINEs might offer new treatment for people with acute leukemia

A novel family of experimental agents that blocks a molecule from shuttling proteins out of the cell nucleus might offer a new treatment for people with acute leukemia, according to a study by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

20 Jun 2012

FDA, EMA grant orphan drug designation to bluebird bio's gene therapy product for adrenoleukodystrophy

bluebird bio, a leader in the development of innovative gene therapies for severe genetic disorders, announced today that both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have granted an orphan drug designation to its investigational gene therapy product for the treatment of adrenoleukodystrophy (ALD).

19 Jun 2012

Exenatide ‑ a better alternative for add-on therapy?

Twice-daily exenatide may offer advantages over the standard glimepiride in patients with Type 2 diabetes inadequately controlled by metformin, suggest findings published in The Lancet.

19 Jun 2012

HCV suppression reduces liver damage

Profound suppression of the hepatitis C virus reduces long-term hepatic inflammation and fibrosis even in patients who do not achieve a sustained virologic response, research demonstrates.

19 Jun 2012

First Edition: June 19, 2012

Today's headlines include more speculation about the political implications of the Supreme Court's much-anticipated health law decision.

19 Jun 2012

SomnoMed and Sleep HealthCenters partner to create National Center for Integrated Dental Sleep Health

SomnoMed and Sleep HealthCenters are pleased to announce a partnership to create the National Center for Integrated Dental Sleep Health (NCIDSH) program.

19 Jun 2012

ASI completes $5.3 million Series A Preferred Stock financing

Ablative Solutions, Inc. (ASI), a privately-held company headquartered in Kalamazoo, MI with offices in Menlo Park, CA announced today that it has completed a Series A Preferred Stock financing, totaling approximately $5.3 million (including the conversion of the bridge financing completed earlier this year), to fund its unique technology platform.

19 Jun 2012

Multi-modal approach reduces pain and side effects of medication following joint replacement surgery

Reducing acute post-surgical pain and side effects of medications for patients undergoing knee and hip replacement surgery is the focus of a new multi-modal approach at Greenwich Hospital in Greenwich, Connecticut.

19 Jun 2012

New patent filed for VAC-3S, an immunotherapy for treating HIV infections

InnaVirVax, a biopharmaceutical company specialized in the research and development of therapeutic and diagnostic innovations focused on immune dysregulation, announced today that a new European patent application has been filed on VAC-3S, a “first-in-class” immunotherapy for the treatment of HIV infections.

19 Jun 2012

Colectomy need in patients with severe ulcerative colitis drastically reduced by Kappaproct

InDex Pharmaceuticals today announced the publication of positive data from the Company's compassionate use program with its lead compound Kappaproct.

19 Jun 2012

Therapy News and Research

Value of pathology review highlighted in node-negative breast cancer

Engaging in daily activities with children can reduce stress among single mothers

NewYork-Presbyterian/WCMC join new MDS Clinical Research Consortium

HCHD to offer APTA-accredited post-professional physical therapy residency programs

Bariatric procedure increases risk of alcohol use disorders two years after surgery

Study identifies critical neurological factor in aggression

Young men with HIV more likely to experience low bone mass

Combination therapy may help defeat pancreatic cancer

Emergence of drug resistance to ARVs has potential to 'curb, and even reverse' gains against HIV

Inserm researchers examine effect of night work on women’s health

KPT-SINEs might offer new treatment for people with acute leukemia

FDA, EMA grant orphan drug designation to bluebird bio's gene therapy product for adrenoleukodystrophy

Exenatide ‑ a better alternative for add-on therapy?

HCV suppression reduces liver damage

First Edition: June 19, 2012

SomnoMed and Sleep HealthCenters partner to create National Center for Integrated Dental Sleep Health

ASI completes $5.3 million Series A Preferred Stock financing

Multi-modal approach reduces pain and side effects of medication following joint replacement surgery

New patent filed for VAC-3S, an immunotherapy for treating HIV infections

Colectomy need in patients with severe ulcerative colitis drastically reduced by Kappaproct

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News